Our Focus

 Life-threatening and chronic fungal infections are a growing public health concern, particularly in immunocompromised individuals and those with chronic diseases.  

There are currently no fungal vaccines or immuno-therapeutics approved for clinical use.

NXT Biologics is addressing this problem by developing a First-in-Class anti-fungal vaccine and monoclonal antibodies that prevent and treat infections due to multiple fungal pathogens.  

Learn More About Our Science